Skip to main content
. 2013 Aug 8;93(2):368–383. doi: 10.1016/j.ajhg.2013.06.013

Table 1.

List of All 28 Genes Discussed and Associated Evidence Supporting or Questioning Their Involvement in ID

Gene (RefSeq Accession Number) Listsa Reason for Highlightb Identification Methodc ID Structural Variations ID Point Mutations Occurrence of Mutations in EVSd Truncated Variants in EVS dN/dS Ratio (#N/#S) Protein Size Implication in ID
AGTR2 (NM_000686.4) L, R, G, E, A T 1 (X; 7) translocation in a female19 c.402del (p.Phe134Leufs5)19 (see Table S4) yes (1 F) 0.731 (19/8) 363 highly questionable (already controversial)20–22
c.62G>T (p.Gly21Val)19,23 10 M, 23 F (htz)
c.971G>A (p.Arg324Gln)19 4 M, 24 F (htz)
c.1009A>G (p.Ile337Val)19 NF
c.157A>T (p.Ile53Phe)24 NF
c.572G>A (p.Gly191Glu)23 NF
MAGT1 (IAP) (NM_032121.5) L, R, G, E T 3 - c.1028T>G (p.Val311_343Gly)25 5 M, 8 F (htz) yes (1 M) 0.453 (15/10) 367 highly questionable
NXF5 (NM_032946.2) L, R, G, A T 1 inv(X)(p21.1;q22) in two males;26,27 deletion disrupting the NXF cluster;28,29 duplication at Xq22.1 disrupting30 and duplicating31NXF5 in one female and one male, respectively - - yes (8 M) 0.783 (30/11) 365 highly questionable
ZNF674 (NM_001039891.2) L, R, E, A T 1 deletion encompassing ZNF673, ZNF674, RP2, SLC9Z7, and CHST7 in one male;32 duplication encompassing ZNF673, ZNF674, and CHST733 c.352G>T (p.Glu118)32 NF yes (19 M) 0.750 (28/10) 581 highly questionable (already controversial)34
c.1235C>A (p.Pro412Leu)32 NF
c.1028C>T (p.Met343Thr)32 49 M, 16 F (hmz), 223 F (htz)
ZNF41 (NM_007130.2) L, R, G, E, A M 1 (X; 7) translocation disrupting ZNF4135 c.332C>T (p.Pro111Leu)35 c.73−42A>C (p.?)35 2 M, 8 F (htz) yes (1 M, 1 F) 0.696 (45/17) 779 highly questionable
5 M, 9 F (htz)
ZNF81 (NM_007137.3) L, R, G, E, A M 1 (X; 9) translocation in one female;36 1.3 Mb duplication encompassing >30 genes at Xp11.23–p11.3 in one male;37 335 kb microduplication bearing two other genes at Xp11.2–p11.3 in one male38 c.536G>A (p.Ser179Asn)36 NF yes (1 M) 0.595 (25/11) 661 questionable
ARHGEF6 (NM_004840.2) L, R, G, E, A M 1 (X; 21) translocation in one male39 c.166−11T>C (p.?)39 5 M, 13 F (htz) no 0.456 (28/18) 776 questionable
ATP6AP2 (NM_005765.2) L, R, G, E, A T 2 - c.321C>T (p.Asp107Asp) (affects splicing)40 NF yes (1 M) 0.444 (14/10) 350 questionable
SRPX2 (NM_014467.2) L, R, G, E, A M 2 - c.980A>G (p.Asn327Ser)41 3 M, 8 F (htz) no 0.728 (31/14) 465 questionable
c.215A>C (p.Tyr72Ser)41 1 M
ZCCHC12 (SIZN1) (NM_173798.2) E M 3 - c.19C>T (p.Arg7Cys)42 5 M, 28 F (htz) no 0.406 (19/14) 402 questionable
c.1031C>T (p.Thr344Ile)42 NF
IGBP1 (NM_001551.2) L, G, E I 2 - 5′ UTR 2 bp substitution affecting IGBP1 expression43 not covered no 0.487 (19/11) 339 never replicated
KIAA2022 (NM_001008537.2) L, R, G, E, A I 1 inv(X)(q13;p22) in two related males44 - NA no 0.441 (54/34) 1,516 never replicated
KLF8 (NM_007250.4) L, R, G, E I 1 (X; 21) translocation leading to a loss of KLF8 expression in a woman45 - NA no 0.831 (16/6) 359 never replicated
NLGN3 (NM_181303.1) L, R, G, E, A I 3 - c.1411C>T (p.Arg451_471Cys) in two ASD brothers46 NF no 0.209 (17/27) 848 never replicated
ZDHHC15 (NM_144969.2) L, G, E I 1 (X; 15) translocation leading to a loss of ZDHHC15 expression in a female47 - NA no 0.628 (17/8) 337 never replicated
ZNF261 (ZMYM3) (NM_201599.2) R I 1 (X; 13) translocation disrupting ZMYM3 in one female48 - NA no 0.232 (31/42) 1,370 never replicated
MAOA (NM_000240.3) L, R, G, E, A I 1 MAOA-MAOB-NDP deletion in subjects with severe ID49 c.886C>T (p.Gln296)50 NF no 0,359 (14/12) 527 never replicated
CCDC22 (NM_014008.3) - I 3 - c.49A>G (p.Thr17Ala)51 NF no 0.809 (40/17) 627 awaiting replication
CLIC2 (NM_001289.4) - I 4 - c.303C>G (p.His101Gln)52 NF no 0.346 (6/5) 247 awaiting replication
CNKSR2 (NM_014927.3) - I 1 partial deletion of CNKSR253 - NA no 0.340 (22/19) 1,034 awaiting replication
FRMPD4 (NM_014728.3) - I 1 partial duplication of FRMPD454 - NA no 0.383 (57/46) 1,322 awaiting replication
HCFC1 (NM_005334.2) - I 2 - chrX: 152890455A>G55 NA no 0.227 (50/80) 2,035 awaiting replication
c.674G>A (p.Ser225Asn)55 NF
NAA10 (NM_003491.2) L I 4 - c.109T>C (p.Ser37Pro)56 NF no 0.074 (2/8) 235 likely in Ogden syndrome but needs further replication in nonsyndromic ID
c.346C>T (p.Arg116Trp)13 NF
RPL10 (NM_006013.3) L, R, G, E, A I 3 - c.616C>A (p.Leu206Met) (ASD)57 NF no 0.154 (2/4) 214 awaiting replication
c.639C>G (p.His213Gln) (ASD)57,58 NF
SHROOM4 (NM_020717.3) L, R, G, E, A I 1 X-autosome translocations in two females;59 Xp11.22 deletion bearing SHROOM4 in one family54 c.3266C>T (p.Ser1089Leu)59 NF yes (1 F) 0.918 (86/28) 1,493 awaiting replication
c.1422A>G (p.Glu474Glu)59 NF
HUWE1 (NM_031407.5) L, R, G, E, A I 1 microduplications encompassing HSD17B10 and HUWE160,61 or HUWE1 alone62 in a total of 16 unrelated families c.12037C>T (p.Arg4013Trp)61 NF no 0.201 (67/105) 4,374 likely
c.8942G>A (p.Arg2981His)61 NF
c.12559C>T (p.Arg4187Cys)61 NF
c.2849T>A (p.Val950Asp) (ASD)63 NF
PTCHD1 (NM_173495.2) L M 1 160 kb deletion leading to a null PTCHD1 in dizygotic ASD twin brothers;64 50–390 kb inherited deletions disrupting PTCHD1 in six ASD male probands;65 90 kb deletion disrupting PTCHD1 in three related ID males;60,66 200 kb deletion in two ID brothers67 c.517A>G (p.Ile173Val)66 2 M, 2 F (htz) no 0.366 (29/25) 888 likely
c.583G>A (p.Val195Ile)66 NF
c.1008_1009delinsTA (p.MetLeu336_337IleIle)66 NF
c.217C>T (p.Leu73Phe)66 1 F (htz)
c.1436A>G (p.Glu479Gly)66 NF
c.1409C>A (p.Ala470Asp)66 NF
c.1076A>G (p.His359Arg)66 NF
SYN 1 (NM_006950.3) L, R, G, E, A M 2 - c.1067G>A (p.Trp356)68 NF no 0.347 (12/12) 705 likely
c.1663C>T (p.Gln555)69 not covered
c.152C>G (p.Ala51Gly)69 11 M, 30 F (htz)
c.1648G>A (p.Ala550Thr)69 not covered
c.1699A>G (p.Thr567Ala)69 not covered

Abbreviations are as follows: L, Lubs et al.;4 R, Ropers et al.;8 G, Greenwood Genetic Center (see Web Resources); E, Emory Genetics Laboratory (see Web Resources); A, Ambry Genetics (see Web Resources); T, truncating variants reported in EVS; M, ID mutations reported in EVS; I, one piece of evidence or study implicating this gene in ID; htz, heterozygous; hmz, homozygous; M, number of males carrying the mutation; F, number of females carrying the mutation; NF, not found; NA, not applicable; N, number of nonsynonymous variants; and S, number of silent variants.

a

Lists in which genes are included.

b

Reason why we discuss this gene in the paper.

c

Approach used for the initial identification, consistent with the information from the text: 1, positional candidate found through rearrangement or CNV; 2, positional candidate located in a linked region; 3, functional candidate; and 4, through exome or X-exome sequencing.

d

Occurrence of ID mutations in EVS.